Trademarkia Logo

Canada

C$
NUCLEOME
FORMALIZED

on 1 May 2025

Last Applicant/ Owned by

Nucleome Therapeutics Limited

Inventa,Botley RoadOxford OX2 0HY

GB

Serial Number

2395996 filed on 13th Feb 2025

NUCLEOME

Trademark usage description

reagents and kits for research, industry and diagnostic purposes [not for medical or veterinary use]; reagents and kits for medical research; biologic Read More

Classification Information


Class [001]
Reagents and kits for research, industry and diagnostic purposes [not for medical or veterinary use]; reagents and kits for medical research; biological preparations for use in research, industry and science; human cells and isogenic cell lines for research or scientific purposes [not for medical or veterinary use].


Classification kind code

12

Class [009]
Computer software; computer platform software; computer database software; computer software for data analysis and reporting; computer software for the sequencing, annotation, analysis, interpretation and reporting of genome data; computer software for potential patient identification, potential patient stratification and medical diagnosis; computer software for drug discovery and research; computer software for research and medical purposes; computer software for analysis of data relating to pharmaceutical development; computer databases; computer database servers; computer software for database management; computer software for creating searchable databases of information and data.


Classification kind code

12

Class [042]
Research and development services; scientific research and development services; biotechnology research and development services; pharmaceutical research and development services; drug discovery; pharmaceutical drug development; research and development services in the field of genomics; structural and functional analysis of genomes; research and development services in the field of bioinformatics; research and development services in the field of personalised medicine; research and development services in the field of precision medicine; research and development services in the field of stratified medicine; research and development in the field of drug discovery; research and development in the field of drug target discovery; research and development services in the field of clinical trial design; research and development services in the field of medical diagnostics; research and development of pharmaceuticals and compounds; research and development of pharmaceutical preparations and medicines; research and development of medicines; medical research and development services; research related to genomics, bioinformatics, personalised medicine, precision medicine, drug discovery; design and development of databases; design and development of computer software; design and development of computer databases; database design and development services; computer database design and development services; design and development of computer software for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; design and development of computer database for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; genome interpretation services; providing computer software and databases as a service for genome sequencing, annotation, interpretation and reporting; providing software and databases as a service for drug discovery and research; providing software and databases as a service for potential patient identification, potential patient stratification or medical diagnosis; providing software and databases as a service for research and medical purposes; information, advisory and consultancy services in relation to all of the aforesaid; cell-line engineering services; gene-editing services; consultancy, advisory and/or information services relating to or connected with the aforementioned services.


Classification kind code

12

Class [044]
Analysis of data for medical and health purposes; providing information, advice and data relating to genetics and pharmaceuticals for medical and health purposes; pharmaceutical services; medical and health services relating to DNA, genetics and genetic testing; providing a computer database featuring information regarding health; consultancy, advisory and/or information services relating to or connected with the aforementioned services.


Classification kind code

12

Mark Details


Serial Number

2395996

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 1st May 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 1st May 2025
Created
Submitted for opposition 31
on 1st May 2025
Formalized
Submitted for opposition 30
on 13th Feb 2025
Filed
Submitted for opposition 228
on 13th Feb 2025
International Registration